Sun Pharmaceutical Industries Ltd
D3 Development, Inc
F. Hoffman-La Roche AG
Lupin Limited, Aurobindo Pharma Ltd
Bausch Health Companies Inc
Skin conditions which are infectious, widespread and simple to treat are seborrheic dermatitis. This type of dermatitis, leads to itchy red spots, greasy scales and white, yellow, or white-like crust on the scalp. The body can develop seborrheic dermatitis in several places. The face/forehead, upper back and chest, wrinkles under the nose, behind the ears, navel (belly button), brows, beneath your breasts, and in the creases/bends of your arms, legs, and crotch are the places with the most sebaceous (oil) gland activity. Growth in the adoption of prescription drugs for treatment of seborrheic dermatitis is projected to compel the growth of market. For instance, few of the prescription-based drugs available in the market for the treatment of seborrheic dermatitis include fluocinolone (capex, synalar), hydrocortisone, clobetasol (clobex, temovate) and desonide (desowen, desonate). Along with this, the increase in the adoption of over-the counter drugs owing to growing number of retail and online pharmacies are likely to fuel the growth of seborrheic dermatitis treatment market. However, the finite primary care services, is a factor limiting the market growth.
The Seborrheic Dermatitis Treatment Market is likely to grow at a rate of 12.2% CAGR by 2028.
The Seborrheic Dermatitis Treatment Market has been segmented as below:
Seborrheic Dermatitis Treatment Market by Dosage form
Seborrheic Dermatitis Treatment Market by Treatment
Seborrheic Dermatitis Treatment Market by Type
Seborrheic Dermatitis Treatment Market by Distribution channel
Seborrheic Dermatitis Treatment Market by Geography
The dosage form segment in the seborrheic dermatitis treatment market is divided as Shampoo, Cream, Ointment, Tablet and Others. Among them the radar segment is having the greatest share in the market. Among them the cream segment is having the greatest share in the market. Due to the high presence of various anti-fungal, anti-inflammatory creams for treatment of seborrheic dermatitis and growth in adoption of over-the-counter creams for treatment of seborrheic dermatitis.
In the treatment segmentation, the autonomous tractor market is classified into Anti fungal, Antibiotics, Others and Anti inflammatory. The antifungal segment holds the considerable share in the market. The effectiveness of antifungal creams, lotions, gels and shampoos for treatment of seborrheic dermatitis is a key factor for the segment growth.
Type segmentation in the seborrheic dermatitis treatment market is classified into Prescription Based Drugs and Over the Counter Drugs. The Prescription Based Drugs segment has occupied a maximum share in the market. This is due to the increase in awareness among the people about the prominence of prescription-based drugs drugs.
The distribution channel segment is majorly divided into Hospital Pharmacy, Retail pharmacy and Online Pharmacy. The Hospital Pharmacy segment is leading the market by distribution channel owing to the rise in the occurance of skin disorders and growth in consultations for seborrheic dermatitis.
The North America region has acquired the highest share in the market based on geography. The rise in the number of autoimmune diseases such as HIV, and psoriasis, technological advancement in the healthcare sector and well developed healthcare infrastructure are the key reasons responsible for the growth of market in the region.
Rise of the global seborrheic dermatitis treatment market share is significantly driven by increase in the number of autoimmune diseases such as HIV (human immunodeficiency virus), and psoriasis, technological advancement in healthcare sector and rise in the number of research activities. Growth in the number of dermatological clinics and surge in number of treatment options for seborrheic dermatitis are projected to boost the global seborrheic dermatitis treatment market growth.
Key competitors operating in the market are Sun Pharmaceutical Industries Ltd, Almirall S.A., D3 Development, Inc, F. Hoffman-La Roche AG, Lupin Limited, Aurobindo Pharma Ltd, Bausch Health Companies Inc., GlaxoSmithKline plc, Leo Pharma A/S, and Medimetricks Pharmaceutical Inc.
The seborrheic dermatitis is a common condition observed in the mass specifically in adults and teenagers. Since, the adults and teens are more conscious regarding their skin and the demand for seborrheic dermatitis treatment is likely to witness a significant growth in the future.
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO – Impact Analysis
5. Dosage form: Market Size & Analysis
5.1. Overview
5.2. Shampoo
5.3. Cream
5.4. Ointment
5.5. Tablet
5.6. Others
6. Treatment: Market Size & Analysis
6.1. Overview
6.2. Anti fungal
6.3. Antibiotics
6.4. Others
6.5. Anti inflammatory
7. Type: Market Size & Analysis
7.1. Overview
7.2. Prescription Based Drugs
7.3. Over the Counter Drugs
8. Distribution channel: Market Size & Analysis
8.1. Overview
8.2. Hospital Pharmacy
8.3. Retail pharmacy
8.4. Online Pharmacy
9. Geography: Market Size & Analysis
9.1. Overview
9.2. North America
9.3. Europe
9.4. Asia Pacific
9.5. Rest of the World
10. Competitive Landscape
10.1. Competitor Comparison Analysis
10.2. Market Developments
10.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
10.2.2. Product Launches and execution
11. Vendor Profiles
11.1. Sun Pharmaceutical Industries Ltd
11.1.1. Overview
11.1.2. Financial Overview
11.1.3. Product Offerings
11.1.4. Developments
11.1.5. Business Strategy
11.2. Almirall S.A.
11.2.1. Overview
11.2.2. Financial Overview
11.2.3. Product Offerings
11.2.4. Developments
11.2.5. Business Strategy
11.3. D3 Development, Inc
11.3.1. Overview
11.3.2. Financial Overview
11.3.3. Product Offerings
11.3.4. Developments
11.3.5. Business Strategy
11.4. F. Hoffman-La Roche AG
11.4.1. Overview
11.4.2. Financial Overview
11.4.3. Product Offerings
11.4.4. Developments
11.4.5. Business Strategy
11.5. Lupin Limited
11.5.1. Overview
11.5.2. Financial Overview
11.5.3. Product Offerings
11.5.4. Developments
11.5.5. Business Strategy
11.6. Aurobindo Pharma Ltd
11.6.1. Overview
11.6.2. Financial Overview
11.6.3. Product Offerings
11.6.4. Developments
11.6.5. Business Strategy
11.7. Bausch Health Companies Inc.
11.7.1. Overview
11.7.2. Financial Overview
11.7.3. Product Offerings
11.7.4. Developments
11.7.5. Business Strategy
11.8. GlaxoSmithKline plc
11.8.1. Overview
11.8.2. Financial Overview
11.8.3. Product Offerings
11.8.4. Developments
11.8.5. Business Strategy
11.9. Leo Pharma A/S
11.9.1. Overview
11.9.2. Financial Overview
11.9.3. Product Offerings
11.9.4. Developments
11.9.5. Business Strategy
11.10. Medimetricks Pharmaceutical Inc
11.10.1. Overview
11.10.2. Financial Overview
11.10.3. Product Offerings
11.10.4. Developments
11.10.5. Business Strategy
12. Analyst Opinion
13. Annexure
13.1. Report Scope
13.2. Market Definitions
13.3. Research Methodology
13.3.1. Data Collation and In-house Estimation
13.3.2. Market Triangulation
13.3.3. Forecasting
13.4. Report Assumptions
13.5. Declarations
13.6. Stakeholders
13.7. Abbreviations
The Seborrheic Dermatitis Treatment Market has been segmented as below:
Seborrheic Dermatitis Treatment Market by Dosage form
Seborrheic Dermatitis Treatment Market by Treatment
Seborrheic Dermatitis Treatment Market by Type
Seborrheic Dermatitis Treatment Market by Distribution channel
Seborrheic Dermatitis Treatment Market by Geography
